Study of ADO-5030 for asthma triggered by airway challenge
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new inhaled medicine, ADO-5030, to see if it helps people with mild or moderate asthma when their airways narrow (bronchoconstriction). You will be asked to breathe in a substance that can trigger asthma symptoms, and the study will check if the medicine helps prevent or reduce that reaction.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had mild or moderate asthma for at least 6 months, and it is well controlled (score of 20 or higher on an asthma control test).
- You are willing to stop taking certain asthma controller medicines (like inhaled steroids, long-acting bronchodilators, and leukotriene modifiers) for 48 hours before the study visits.
- You are not a current smoker and have not smoked in the past year, and your smoking history is less than 10 pack-years (e.g., one pack a day for 10 years).
- You are willing to avoid caffeine for 24 hours before each airway challenge test.
- You are not pregnant or nursing, and if sexually active, you agree to use reliable birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
This study follows people with moderate-to-severe asthma and repeatedly checks how their lungs and symptoms relate to environmental exposures over time. It may help researchers better understand what triggers asthma and how exposures affect asthma control.
This study tests a new, non-invasive way to measure airway inflammation after breathing in an allergen (like pollen or dust mite). It is for people with mild asthma that is well controlled with only a rescue inhaler.
This study tests an investigational medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with current treatments. The goal is to see if it can reduce asthma attacks and improve breathing.
This study tests an investigational drug (called JNJ-95597528) taken as a pill, to see if it can reduce asthma attacks and improve control in people with moderate to severe asthma that isn't well controlled by current inhalers. It may be a new option to help reduce airway inflammation and improve your breathing.
This study tests an experimental medicine (PF-08103402) to see how well it is tolerated and how it acts in the body, in healthy adults and in people with mild-to-moderate asthma. Participation may help researchers learn if this treatment could help manage asthma symptoms.
Hear when a new Asthma (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.